IPP Bureau
Zydus receives final approval from the USFDA for Estradiol Transdermal System
By IPP Bureau - April 19, 2023
Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of USD 1.9 mn in the United States
Everest Medicines partners with Shanghai Pharma Subsidiary to accelerate the commercialization of XERAVA in Mainland China
By IPP Bureau - April 19, 2023
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Enterprise Informatics central to solving productivity, staff and patient experience challenges, says Philips
By IPP Bureau - April 18, 2023
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
Vaniam appoints Paula Franson to lead Clinical Strategy & Solutions
By IPP Bureau - April 18, 2023
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Ascentage presents results of studies underscoring exploratory efforts in potential
By IPP Bureau - April 18, 2023
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
DualityBio collaborates with BioNTech to accelerate development of differentiated antibody-drug conjugate therapeutics
By IPP Bureau - April 18, 2023
WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.
Agilent showcases cancer portfolio Solutions at AACR 2023
By IPP Bureau - April 18, 2023
From cancer research to diagnostic solutions
Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices
By IPP Bureau - April 17, 2023
The blood test market worldwide is today around $75-80 billion
Zydus receives final approval from the USFDA for Isoproterenol Hydrochloride Injection
By IPP Bureau - April 17, 2023
Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output
CII co-organizes Digital Health Summit 2023 with Health Ministry
By IPP Bureau - April 17, 2023
The Theme of the event was 'Building One Health Together – Improving Health Equity'
G 20: 2nd Health Working Group Meeting discusses global collaboration in research and regional manufacturing for diagnostics
By IPP Bureau - April 17, 2023
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
By IPP Bureau - April 17, 2023
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Moderna and Merck announce an investigational individualized neoantigen therapy
By IPP Bureau - April 17, 2023
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
Fibe partners with Pristyn Care to power affordable quality healthcare across India
By IPP Bureau - April 15, 2023
Affordability is key to providing accessible healthcare for Bharat.
NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate
By IPP Bureau - April 15, 2023
Study efficacy measures will include the expression of dystrophin protein and motor function.
